Key Laboratory of Systems Microbial Biotechnology, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China; High-throughput Molecular Drug Discovery Center, Tianjin Joint Academy of Biotechnology and Medicine, Tianjin 300457, China.
High-throughput Molecular Drug Discovery Center, Tianjin Joint Academy of Biotechnology and Medicine, Tianjin 300457, China.
Anal Chim Acta. 2015 Jul 30;886:98-106. doi: 10.1016/j.aca.2015.06.017. Epub 2015 Jul 9.
Binding affinity of a small molecule drug candidate to a therapeutically relevant biomolecular target is regarded the first determinant of the candidate's efficacy. Although the ultrafiltration-LC/MS (UF-LC/MS) assay enables efficient ligand discovery for a specific target from a mixed pool of compounds, most previous analysis allowed for relative affinity ranking of different ligands. Moreover, the reliability of affinity measurement for multiple ligands with UF-LC/MS has hardly been strictly evaluated. In this study, we examined the accuracy of K(d) determination through UF-LC/MS by comparison with classical ITC measurement. A single-point K(d) calculation method was found to be suitable for affinity measurement of multiple ligands bound to the same target when binding competition is minimized. A second workflow based on analysis of the unbound fraction of compounds was then developed, which simplified sample preparation as well as warranted reliable ligand discovery. The new workflow implemented in a fragment mixture screen afforded rapid and sensitive detection of low-affinity ligands selectively bound to the RNA polymerase NS5B of hepatitis C virus. More importantly, ligand identification and affinity measurement for mixture-based fragment screens by UF-LC/MS were in good accordance with single ligand evaluation by conventional SPR analysis. This new approach is expected to become a valuable addition to the arsenal of high-throughput screening techniques for fragment-based drug discovery.
小分子药物候选物与治疗相关生物分子靶标的结合亲和力被认为是候选物疗效的第一个决定因素。虽然超滤 - 液相色谱/质谱(UF-LC/MS)测定法能够从化合物的混合池中有效地发现针对特定靶标的配体,但以前的大多数分析仅允许对不同配体进行相对亲和力排序。此外,UF-LC/MS 对多种配体的亲和力测量的可靠性几乎没有得到严格评估。在这项研究中,我们通过与经典 ITC 测量的比较,检查了通过 UF-LC/MS 确定 K(d)的准确性。当结合竞争最小化时,单点 K(d)计算方法被发现适用于结合到同一靶标上的多种配体的亲和力测量。然后开发了基于化合物未结合部分分析的第二个工作流程,该方法简化了样品制备并保证了可靠的配体发现。在片段混合物筛选中实施的新工作流程能够快速灵敏地检测选择性结合丙型肝炎病毒 RNA 聚合酶 NS5B 的低亲和力配体。更重要的是,UF-LC/MS 进行的基于混合物的片段筛选的配体鉴定和亲和力测量与传统 SPR 分析的单一配体评估非常吻合。这种新方法有望成为基于片段的药物发现高通量筛选技术的有力补充。